2019
DOI: 10.3233/jad-190888
|View full text |Cite
|
Sign up to set email alerts
|

Low-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex Enhances Recognition Memory in Alzheimer’s Disease

Abstract: Background: The lack of effective pharmacological or behavioral interventions for memory impairments associated with Alzheimer's disease (AD) emphasizes the need for the investigation of approaches based on neuromodulation. Objective: This study examined the effects of inhibitory repetitive transcranial magnetic stimulation (rTMS) of prefrontal cortex on recognition memory in AD patients. Methods: In a first experiment, 24 mild AD patients received sham and real 1Hz rTMS over the left and right dorsolateral pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
40
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(44 citation statements)
references
References 51 publications
4
40
0
Order By: Relevance
“…Although rTMS has been used to treat AD in clinic, specific treatment schemes are not unified, and the mechanism is unclear. Thus, the research on rTMS to treat AD needs further investigation (Alcalá‐Lozano et al., 2018; Sabbagh et al., 2019; Turriziani et al., 2019). Recent studies have focused on the cognitive impairment of rTMS in AD model mice or patients, and there are few reports on the characteristic pathological changes and the mechanism of AD lesions (Huang et al., 2017; Ma et al., 2017).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although rTMS has been used to treat AD in clinic, specific treatment schemes are not unified, and the mechanism is unclear. Thus, the research on rTMS to treat AD needs further investigation (Alcalá‐Lozano et al., 2018; Sabbagh et al., 2019; Turriziani et al., 2019). Recent studies have focused on the cognitive impairment of rTMS in AD model mice or patients, and there are few reports on the characteristic pathological changes and the mechanism of AD lesions (Huang et al., 2017; Ma et al., 2017).…”
Section: Discussionmentioning
confidence: 99%
“…Although rTMS has been used to treat AD in clinic, specific treatment schemes are not unified, and the mechanism is unclear. Thus, the research on rTMS to treat AD needs further investigation (Alcalá-Lozano et al, 2018;Sabbagh et al, 2019;Turriziani et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Since most of the cognitive functions impaired in AD are related to memory recall, problem-solving, reasoning and emotional control, prefrontal regions are the main targets of NIBS. Turriziani et al [52] stimulated the right dorsolateral prefrontal cortex (DLPFC) with LF-rTMS for 10 min before a non-verbal recognition memory task. They observed improved memory performances following the real stimulation on the right DLPFC compared to the right-sham stimulation.…”
Section: Transcranial Magnetic Stimulation-tmsmentioning
confidence: 99%
“…Protocol Results [18] HF ** (20 Hz), bilaterally Improved action naming [19] HF (20 Hz), bilaterally Improved action naming in milder cognitive decline Improved general naming in moderate to severe cognitive decline [20] HF (20 Hz), left Improved auditory sentence comprehension, persisted for 2 months [21] HF (10 Hz), left Improved neuropsychological test scores and daily functioning [22] HF (20 Hz)/LF * 3 (1 Hz), bilaterally Improved cognitive function and mood in the HF group, persisted for 3 months [23] HF (20 Hz), bilaterally Improved cognitive function and behaviorImproved word-image association [24] HF (20 Hz), left Improved cognitive function and behavior [25] LF (…”
Section: Referencementioning
confidence: 99%